ADHD matures: Time for practitioners to do the same?

Journal of Psychopharmacology

Volumn 26, Issue 6, 2012, Pages 766-770

  Bolea, B ^a   Adamou, M ^b   Arif, M ^c   Asherson, P ^d   Gudjonsson, G ^d   Muller U ^e   Nutt, D J ^f   Pitts, M ^g   Thome, J ^h   Young, S ^d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTH WEST YORKSHIRE PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^c LEICESTERSHIRE PARTNERSHIP NHS TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

ADD; ADHD; drug treatment; hyperactivity; hyperkinetic disorder; inattention; methylphenidate; service provision

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADDICTION; ADULTHOOD; ATTENTION DEFICIT DISORDER; BRAIN DISEASE; CLINICAL FEATURE; COMORBIDITY; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; CULTURAL FACTOR; DRUG EFFICACY; HEALTH CARE UTILIZATION; HUMAN; INHERITANCE; MENTAL HEALTH CARE; NEUROIMAGING; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SUBSTANCE ABUSE; UNEMPLOYMENT; UNITED KINGDOM;

ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FOLLOW-UP STUDIES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS;

EID: 84862117887     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111410898     Document Type: Review

References (49)

1. Adler LA, Spencer TJ, Levine LR, et al. Functional outcomes in the treatment of adults with ADHD. J Atten Disord. 2008 ; 11: 720-727
2. Arcos-Burgos M, Jain M, Acosta MT, et al. Common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry. 2010 ; 15: 1053-1066
3. Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008 ; 33: 1199-207
4. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Review of Neurotherapeutics. 2005 ; 5: 525-539
5. Biederman J, Faraone SV, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry. 1992 ; 49: 728-738
6. Biederman J, Faraone SV, Knee D, et al. Retrospective assessment of DSM-III attention deficit disorder in non referred individuals. J Clin Psychiatry. 1990 ; 51: 102-106
7. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991 ; 148: 564-577
8. Bradley C. Benzedrine and Dexedrine in the treatment of children's behaviour disorders. Pediatrics. 1950 ; 5: 24-37
9. Carpentier PJ, van Gogh MT, Knapen LJ, et al. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 2011. 2010 ; 17 (1). 10-20
10. Crichton A. An enquiry into the nature and origin of mental derangement: On attention and its diseases. J Atten Disord. 2008 ; 12: 200
11. De Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008 ; 65: 835-842
12. Edvinsson D, Bingefors K, Lindström E, et al. ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Ups J Med Sci. 2010 ; 115: 30-40
13. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007 ; 190: 402-409
14. Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/ hyperactivity disorder in adults: An overview. Biol Psychiatry. 2000 ; 48: 9-20
15. Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010 ; 19: 353-364
16. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010 ; 71: 754-763
17. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 ; 57: 1313-1323
18. Faraone SV, Sergeant J, Gillberg C, et al. The worldwide prevalence of ADHD. Is it an American condition?. World Psychiatry. 2003 ; 2: 2
19. Fassbender C, Schweitzer JB. Is there evidence for neural compensation in attention deficit hyperactivity disorder? A review of the functional neuroimaging literature. Clin Psychol Rev. 2006 ; 26: 445-465
20. Gittelman R, Mannuzza S, Shenker R, et al. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry. 1985 ; 42: 937-947
21. Goksøyr PK, Nøttestad JA. The burden of untreated ADHD among adults: the role of stimulant medication. Addict Behav. 2008 ; 33: 342-346
22. Goldstein S. Is ADHD a growth industry?. J Atten Disord. 2006 ; 9: 461-464
23. Greenfield B, Hechtman L, Weiss G. Two subgroups of hyperactives as adults: correlations of outcome. Can J Psychiatry. 1988 ; 33: 505-508
24. Hesse S, Ballaschke O, Barthel H, et al. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder. Psychiatry research. Neuroimaging. 2009 ; 171: 120-128
25. Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD The European Network Adult ADHD. BMC Psychiatry. 2010 ; 10: 67
26. Krause KH, Dresel SH, Krause J, et al. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett. 2000 ; 285: 107-110
27. Krause J, La Fougere C, Krause KH, et al. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci. 2005 ; 255: 428-431
28. NICE (National Institute for Health and Clinical Excellence) (2008) Attention deficit hyperactivity disorder: the diagnosis and management of ADHD in children, young people and adults. Available at: www.nice.org.uk/nicemedia/ pdf/CG72NiceGuidelinev3.pdf (accessed 11 May 2011).
29. Nutt DJ, Fone K, Asherson P, et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007 ; 21: 10-41
30. Mannuzza S, Klein RG, Bonagura N, et al. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry. 1991 ; 48: 77-83
31. Mészáros A, Czobor P, Bálint S, et al. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int Neuropsychopharmacol. 2009 ; 12: 1137-1147
32. O'Gorman R, Mehta MA, Asherson P, et al. Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalized by stimulant treatment: A non-invasive MRI pilot study. Neuroimaging. 2008 ; 42: 36-41
33. Polanczyk G, De Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007 ; 164: 942-948
34. Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes, Brain, and Behavior. 2011 ; 10: 149-157
35. Rösler M, Retz W, Retz-Junginger P, et al. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci. 2004 ; 254: 365-367
36. Schneider MF, Krick CM, Retz W, et al. Impairment of fronto-striatal and parietal cerebral networks correlates with attention deficit hyperactivity disorder (ADHD) psychopathology in adults-a functional magnetic resonance imaging (fMRI) study. Psychiatry Res. 2010 ; 183: 75-84
37. Schneider M, Retz W, Coogan A, et al. Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)-a neurological view. Eur Arch Psychiatry Clin Neurosci. 2006 ; 256 (Suppl 1). i32 - i41
38. Shaw P, Rabin C. New insights into attention-deficit/hyperactivity disorder using structural neuroimaging. Curr Psychiatry Rep. 2009 ; 11: 393-398
39. Simon V, Czobor P, Bálint S, et al. valence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009 ; 194: 204-211
40. Singh I. Beyond polemics: science and ethics of ADHD. Nat Rev Neurosci. 2008 ; 9: 957-964
41. Spencer TJ, Landgraf JM, Adler LA, et al. Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2008 ; 69: 1766-1775
42. Still GF. Some abnormal psychical conditions in children: Excerpts from three lectures. J Atten Disord. 2006 ; 10: 126
43. Wender PH, Reimherr FW, Wood DR. Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment. Arch Gen Psychiatry. 1981 ; 38: 449-456
44. Wood DR, Reimherr FW, Wender PH, et al. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry. 1976 ; 33: 1453-1460
45. Yan WW. An investigation of adult outcome of hyperactive children in Shanghai. Psychiatry Clin Neurosci. 1998 ; 52 (Suppl): S303 - S305
46. Young S, Adamou M, Bolea B, et al. The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies. BMC Psychiatry. 2011 ; 11: 32
47. Young S, Amarasinghe JM. Practitioner review: Non-pharmacological treatments for ADHD: a lifespan approach. J Child Psychol Psychiatry. 2010 ; 51: 116-1133
48. Young S, Gudjonsson GH, Misch P, et al. Prevalence of ADHD symptoms among youth in a secure facility: The consistency and accuracy of self- and informant-report ratings. J Forensic Psychiatry Psychol. 2010 ; 21: 238-246
49. Young S, Gudjonsson G, Wells J, et al. Attention Deficit Hyperactivity Disorder and critical incidents in a Scottish prison population. Pers Individ Diff. 2009 ; 46: 265-269